.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Department of Justice
Chubb
Deloitte
Cerilliant
Mallinckrodt
Baxter
QuintilesIMS
Citi
Covington

Generated: December 17, 2017

DrugPatentWatch Database Preview

Actavis Labs Fl Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has seventy-three approved drugs.

There are two tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl

US Patents:0
Tradenames:58
Ingredients:56
NDAs:73
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl IncBENAZEPRIL HYDROCHLORIDEbenazepril hydrochlorideTABLET;ORAL076267-004Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncALPRAZOLAMalprazolamTABLET, EXTENDED RELEASE;ORAL077198-004May 13, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncBUPROPION HYDROCHLORIDEbupropion hydrochlorideTABLET, EXTENDED RELEASE;ORAL079095-002Mar 24, 2009AB1RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncPALIPERIDONEpaliperidoneTABLET, EXTENDED RELEASE;ORAL202645-002Aug 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncTRANEXAMIC ACIDtranexamic acidTABLET;ORAL202093-001Dec 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncRISPERIDONErisperidoneTABLET, ORALLY DISINTEGRATING;ORAL076996-001Apr 19, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncALPRAZOLAMalprazolamTABLET, EXTENDED RELEASE;ORAL077198-001May 13, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncPALIPERIDONEpaliperidoneTABLET, EXTENDED RELEASE;ORAL202645-004Aug 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncMETOPROLOL SUCCINATEmetoprolol succinateTABLET, EXTENDED RELEASE;ORAL077298-002Apr 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncNAPROXEN SODIUMnaproxen sodiumTABLET, EXTENDED RELEASE;ORAL075416-003Aug 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ACTAVIS LABS FL drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazoleDelayed-release Tablets20 mgOMEPRAZOLE6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Julphar
US Department of Justice
Cipla
Baxter
Moodys
Queensland Health
Fuji
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot